274 related articles for article (PubMed ID: 32833221)
1. Living Donor Versus Deceased Donor Liver Transplantation for HCC.
Doğan SM; Kutlutürk K
J Gastrointest Cancer; 2020 Dec; 51(4):1104-1106. PubMed ID: 32833221
[TBL] [Abstract][Full Text] [Related]
2. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
[TBL] [Abstract][Full Text] [Related]
3. Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?
Vining CC; Ecker BL; Abt PL; Olthoff KM
Liver Transpl; 2017 Oct; 23(S1):S27-S33. PubMed ID: 28846212
[No Abstract] [Full Text] [Related]
4. Liver transplantation in Germany.
Tacke F; Kroy DC; Barreiros AP; Neumann UP
Liver Transpl; 2016 Aug; 22(8):1136-42. PubMed ID: 27082951
[TBL] [Abstract][Full Text] [Related]
5. Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?
Akbulut S; Koc C
J Gastrointest Cancer; 2020 Dec; 51(4):1107-1113. PubMed ID: 32857265
[TBL] [Abstract][Full Text] [Related]
6. Living donor liver transplantation for hepatocellular carcinoma: a single centre experience.
Pandey D; Wai CT; Lee KH; Tan KC
Indian J Gastroenterol; 2008; 27(4):148-52. PubMed ID: 18974464
[TBL] [Abstract][Full Text] [Related]
7. Liver Donation and Transplantation in Poland: Numbers, Indicators, and Trends.
Czerwiński J; Lewandowska D; Małkowski P; Danielewicz R
Transplant Proc; 2016 Jun; 48(5):1341-6. PubMed ID: 27496401
[TBL] [Abstract][Full Text] [Related]
8. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
Sugawara Y; Tamura S; Makuuchi M
Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center.
Jonas S; Mittler J; Pascher A; Schumacher G; Theruvath T; Benckert C; Rudolph B; Neuhaus P
Liver Transpl; 2007 Jun; 13(6):896-903. PubMed ID: 17538994
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
[TBL] [Abstract][Full Text] [Related]
11. Section 4. Further expanding the criteria for HCC in living donor liver transplantation: the Tokyo University experience.
Tamura S; Sugawara Y; Kokudo N
Transplantation; 2014 Apr; 97 Suppl 8():S17-20. PubMed ID: 24849823
[TBL] [Abstract][Full Text] [Related]
12. Living donor liver transplantation for hepatocellular carcinoma.
Lee SG; Moon DB
Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
[TBL] [Abstract][Full Text] [Related]
13. Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
Tohyama T; Sakamoto K; Tamura K; Nakamura T; Watanabe J; Wakisaka H; Takada Y
World J Surg Oncol; 2020 May; 18(1):109. PubMed ID: 32466780
[TBL] [Abstract][Full Text] [Related]
14. Liver Transplantation in France.
Durand F; Antoine C; Soubrane O
Liver Transpl; 2019 May; 25(5):763-770. PubMed ID: 30697904
[TBL] [Abstract][Full Text] [Related]
15. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599
[TBL] [Abstract][Full Text] [Related]
16. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
17. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
[TBL] [Abstract][Full Text] [Related]
19. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis.
Cheng SJ; Pratt DS; Freeman RB; Kaplan MM; Wong JB
Transplantation; 2001 Sep; 72(5):861-8. PubMed ID: 11571451
[TBL] [Abstract][Full Text] [Related]
20. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]